Skip to content

TuHURA Biosciences, Inc. HURA Balance Sheet Statement

FY'25FY'24FY'23FY'22
$3.62M-71.4%$12.66M+245%$3.67M-24.8%$4.87M
$4.62M-76.4%$19.61M+372%$4.16M-54.7%$9.18M
$300.64K+144%$123.37K-32.3%$182.17K-75.3%$739K
$384.53K+93.1%$199.16K+857%$20.82K
$10.74M
$33.77K0.0%$33.77K
$27.35M+37.0%$19.97M+358%$4.36M-56.0%$9.92M
$5.52M+6.8%$5.17M+50.4%$3.44M+27.8%$2.69M
$199.04K+24.5%$159.84K+668%$20.82K
$5.92M+11.1%$5.33M+48.2%$3.6M+11.0%$3.24M
$197.92K
$303.63K+611%$42.7K
$6.42M+19.5%$5.37M-9.3%$5.92M+78.4%$3.32M
$59.34K+40.2%$42.32K+248%$12.17K+508%$2K
$161.78M+29.0%$125.4M+44.3%$86.89M-38.2%$140.57M
-$141.18M-27.1%-$111.12M-25.6%-$88.47M+38.9%-$144.77M
$20.93M+43.4%$14.59M+1,036%-$1.56M-113%$12.3M-12.8%
$27.35M+37.0%$19.97M+358%$4.36M-56.0%$9.92M
$501.19K-47.7%$958.71K+94.2%$493.77K
$500K
$33.77K0.0%$33.77K
$384.53K+93.1%$199.16K+857%$20.82K
$11.28M
$384.53K+93.1%$199.16K+857%$20.82K
$33.77K0.0%$33.77K
$384.53K+93.1%$199.16K+857%$20.82K
$33.77K0.0%$33.77K
$5.52M+6.8%$5.17M+50.4%$3.44M+27.8%$2.69M
$197.35K
$2.32M
$502.67K+148%$202.54K+873%$20.82K
$161.78M+29.0%$125.4M+44.3%$86.89M-38.2%$140.57M
$59.34K+40.2%$42.32K+248%$12.17K+508%$2K
$197.92K

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are TuHURA Biosciences, Inc.'s total assets?
TuHURA Biosciences, Inc. (HURA) holds $29.7M in total assets, up 102.9% year over year.
How much debt does TuHURA Biosciences, Inc. have?
TuHURA Biosciences, Inc. carries $456.9K in total debt against $23.2M of shareholders' equity, a debt-to-equity ratio of 0.02.
How much cash does TuHURA Biosciences, Inc. have?
TuHURA Biosciences, Inc. holds $6.3M in cash and equivalents.
Can TuHURA Biosciences, Inc. cover its short-term obligations?
Its current ratio is 1.15 — current assets exceed current liabilities.
Where does TuHURA Biosciences, Inc.'s balance sheet data come from?
Every line is extracted from TuHURA Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.